Is hunger a driver of the cognitive development? [1]

Neuropsychopharmacology

Volumn 31, Issue 10, 2006, Pages 2326-2327

  Treuer, Tamas ^a   Karagianis, Jamie ^b  

^a Neuroscience Research   (Hungary)

^b Clinical Research   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN;

COGNITION; COGNITIVE DEFECT; ENERGY EXPENDITURE; FOOD INTAKE; HUMAN; HUNGER; LETTER; NEUROENDOCRINOLOGY; NEUROPSYCHIATRY; OBESITY; PRIORITY JOURNAL; SCHIZOPHRENIA; WEIGHT GAIN;

COGNITION; HUMANS; HUNGER; SATIATION;

EID: 33748764934     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301144     Document Type: Letter

References (9)

1. Ascher-Svanum H, Stensland MD, Kinon BJ, Tollefson GD (2005). Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic. J Psychopharmacol 19(Suppl): 110-117.
2. Copinschi G (2005). Metabolic and endocrine effects of sleep deprivation. Essent Psychopharmacol 6: 341-347.
3. Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B et al (2006). Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9: 381-388.
4. Elman I, Borsook D, Lukas SE (2006). Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 31: 1-30.
5. Karagianis J (2003). Evolutionary perspectives on schizophrenia. Can J Psychiatry 48: 641.
6. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209-1223.
7. Murashita M, Kusumi I, Inoue T, Takahashi Y, Hosoda H, Kangawa K et al (2005). Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology 30: 106-110.
8. Polimeni J, Reiss JP (2003). Evolutionary perspectives on schizophrenia. Can J Psychiatry 48: 34-39.
9. Sussman N (2001). Review of atypical antipsychotics and weight gain. J Clin Psychiatry 62: 5-13.